A. Payne

发表

A study of prospective surveillance for inhibitors among persons with haemophilia in the United States

C. Kempton, A. Neff, D. Brettler, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

COVID-19 and Sickle Cell Disease–Related Deaths Reported in the United States

M. Hulihan, L. Schieve, W. Hooper, 2022, Public health reports.

Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009–2015

C. Reed, L. Schieve, D. Shay, 2021, Pediatric blood & cancer.

Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen‐Bethesda assay for factor VIII inhibitors

C. Bean, C. Miller, A. Payne, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Magnetic resonance angiography‐defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose‐6‐phosphate dehydrogenase mutation in children with sickle cell anaemia

Bruce A. Vendt, R. McKinstry, M. DeBaun, 2012, British journal of haematology.

Invasive Pneumococcal Disease Among Children With and Without Sickle Cell Disease in the United States, 1998 to 2009

R. Link-Gelles, W. Hooper, J. Jorgensen, 2013, The Pediatric infectious disease journal.

The CDC Hemophilia A Mutation Project (CHAMP) Mutation List: A New Online Resource

C. Miller, F. Kelly, A. Payne, 2013, Human mutation.

Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20–May 21, 2020

L. Schieve, G. Peacock, J. Panepinto, 2020, Emerging infectious diseases.

High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

H. Austin, W. Hooper, C. Miller, 2014, Ethnicity & disease.

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity

W. Hooper, C. Miller, J. Soucie, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety project

M. Hulihan, T. Coates, S. Majumdar, 2021, British journal of haematology.

Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases

N. Dowling, J. Griffin, F. España, 2017, Research and practice in thrombosis and haemostasis.

Mutation analysis of a cohort of US patients with hemophilia B

W. Hooper, C. Miller, A. Payne, 2014, American journal of hematology.

Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening

C. Leissinger, J. Gill, C. Miller, 2015, American journal of hematology.

Utility of multiplex ligation‐dependent probe amplification (MLPA) for hemophilia mutation screening

W. Hooper, C. Miller, C. Bean, 2012, Journal of thrombosis and haemostasis : JTH.

Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States

P. Kouides, V. Byams, C. Miller, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States

T. Buckner, V. Byams, C. Miller, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

The CDC Hemophilia B mutation project mutation list: a new online resource

C. Miller, A. Payne, W. Craig Hooper, 2013, Molecular genetics & genomic medicine.

Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

Manish M Patel, A. Randolph, I. Harwayne-Gidansky, 2021, JAMA network open.

Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

M. DeBaun, S. Ofori-Acquah, W. Hooper, 2012, Blood.

Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.

J. Mehal, W. Hooper, L. Richardson, 2020, Annals of emergency medicine.

cell disease reduced incidence of acute chest syndrome among children with sickle Heme oxygenase-1 gene promoter polymorphism is associated with

M. DeBaun, S. Ofori-Acquah, W. Hooper, 2013 .

Child, Household, and Caregiver Characteristics Associated with Hospitalization for Influenza Among Children 6–59 Months of Age

W. Schaffner, R. Link-Gelles, R. Lynfield, 2014, The Pediatric Infectious Disease Journal.

Low forced expiratory volume is associated with earlier death in sickle cell anemia.

M. DeBaun, R. Strunk, A. Kassim, 2014, Blood.

Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022

Matthew M. Cole, I. Spicknall, A. Gundlapalli, 2022, MMWR. Morbidity and mortality weekly report.

Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus.

A. Payne, S. Badawy, A. B. Payne, 2019, Blood advances.

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022

Matthew M. Cole, Elizabeth A Torrone, E. Banerjee, 2022, MMWR. Morbidity and mortality weekly report.

Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose — 32 U.S. Jurisdictions, July 31–September 3, 2022

Elizabeth B White, I. Spicknall, A. Gundlapalli, 2022, MMWR. Morbidity and mortality weekly report.

Exercise capacity and clinical outcomes in adults followed in the Cooperative Study of Sickle Cell Disease (CSSCD)

A. Payne, S. Badawy, M. Rodeghier, 2018, European journal of haematology.

HLA-DRB1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study.

C. Kempton, A. Payne, Amanda B. Payne, 2018, Blood advances.

HLA-DRB 1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia : a case-control study

C. Kempton, A. Payne, Amanda B. Payne, 2022 .

Seroepidemiologic Survey of Epidemic Cholera in Haiti to Assess Spectrum of Illness and Risk Factors for Severe Disease

Gordana Derado, Brendan R. Jackson, Peter Gerner-Smidt, 2013, The American journal of tropical medicine and hygiene.

Epidemiology of cerebral venous sinus thrombosis and cerebral venous sinus thrombosis with thrombocytopenia in the United States, 2018 and 2019

L. Schieve, W. Hooper, L. Richardson, 2022, Research and practice in thrombosis and haemostasis.

Acute chest syndrome is associated with single nucleotide polymorphism‐defined beta globin cluster haplotype in children with sickle cell anaemia

M. DeBaun, J. Keefer, W. Hooper, 2013, British journal of haematology.

Mortality Trends and Causes of Death in Persons with Sickle Cell Disease in the United States, 1979-2014

J. Mehal, W. Hooper, L. Richardson, 2017 .

Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors

C. Miller, C. Bean, A. Payne, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.

Elizabeth A Torrone, E. Banerjee, A. Payne, 2023, American Journal of Transplantation.

Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023

R. Link-Gelles, A. Fleischauer, Heather M. Scobie, 2023, MMWR. Morbidity and mortality weekly report.